FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

12 letters match. Newest first.

  1. Owen Biosciences, Inc.

    Owen Biosciences' over-the-counter benzoyl peroxide acne lotion had over 20 parts per million benzene and lacked release testing.

    High risk
  2. Seema International

    FDA warns Seema International over unclean API equipment, missing stability data, and quality-unit failures after inspection; APIs adulterated.

    High risk
  3. Dixon Investments Inc. dba ARI

    FDA cites Dixon Investments (ARI) for manufacturing-rule and unapproved/misbranded OTC aerosol drug violations.

    High risk
  4. Baldwin Richardson Foods Pennsauken, LLC

    FDA warned Baldwin Richardson Foods Pennsauken of serious low-acid canned food violations after finding microbial growth and process-control failures in aseptic non-dairy beverages.

    High risk
  5. Ya Ya Foods USA, LLC

    FDA warned Ya Ya Foods USA that its aseptic oat milk made in Ogden, Utah, was adulterated after an inspection found processing deviations.

    High risk
  6. Brenntag Great Lakes, LLC

    Brenntag Great Lakes failed to prevent cross-contamination of OTC hand sanitizer made on equipment shared with industrial chemicals.

    High risk
  7. Premier Nutra Pharma Inc.

    FDA cited Premier Nutra Pharma, a Carlsbad, California contract maker of nasal spray drugs, for CGMP violations after microbial contamination.

    High risk
  8. Pop Daddy Popcorn, LLC

    FDA warns Pop Daddy Popcorn over insanitary conditions and food safety rule violations for ready-to-eat pretzels.

    High risk
  9. Custom Research Labs Inc.

    FDA warned Custom Research Labs Inc. about manufacturing-practice violations and unapproved, misbranded OTC drugs, including hand sanitizers and topical analgesics.

    High risk
  10. Bi-Coastal Pharma International

    FDA warned Bi-Coastal Pharma International about adulterated drugs due to poor complaint handling, quality-unit oversight, batch release, and training.

    High risk
  11. Yakamoz Sirke Ferm Urunleri Gida Tas San Ve Tic Ltd STI

    FDA says Turkish juice maker Yakamoz lacked a validated HACCP (juice safety) plan for lemon and lime juice.

    High risk
  12. Yuyao YiJia Daily Chemical Co., Ltd.

    Yuyao YiJia, a Chinese OTC drug and hand sanitizer maker, lacked finished-product, component and stability testing and an adequate quality unit.

    High risk